List of publications

All the publications of the C3M teams.

Export in CSV
A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.

Authors Arrault A, Rocchi S, Picard F, Maurois P, Pirotte B, Vamecq J

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jan 2008

The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain.

Authors Maurois P, Rocchi S, Pages N, Bac P, Stables JP, Gressens P, Vamecq J

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Dec 2007

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.

Authors Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG

Journal of immunology (Baltimore, Md. : 1950) Jun 2007

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.

Authors Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG

Journal of immunology (Baltimore, Md. : 1950) Jun 2007

Toll-like receptors and atopy.

Authors Fiset PO, Tulic MK, Hamid Q

The Journal of allergy and clinical immunology Aug 2005

Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production.

Authors Hajoui O, Janani R, Tulic M, Joubert P, Ronis T, Hamid Q, Zheng H, Mazer BD

The Journal of allergy and clinical immunology Sep 2004

Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model.

Authors Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA

The Laryngoscope May 2004

Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model.

Authors Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA

The Laryngoscope May 2004

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

Authors Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q

The Journal of allergy and clinical immunology Feb 2004

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

Authors Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q

The Journal of allergy and clinical immunology Feb 2004